Gopi Shankar
Equibles does not estimate personal net worth.
Get an email with a short summary when Larimar Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get LRMR alertsAbout Gopi Shankar
The proxy statement of Larimar Therapeutics, Inc. reports total compensation of $1,293,329 for Gopi Shankar in fiscal 2025, including a base salary of $466,003. Disclosed compensation is on record for 4 fiscal years. Larimar Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Larimar Therapeutics, Inc. includes Carole Ben-Maimon (CEO and Board Member), Carole S. Ben-Maimon (CEO and Board Member), Joseph Truitt (Chairman and Board Member) and 7 others.
Affiliation history
-
Larimar Therapeutics, Inc. (LRMR)
Proxy statement
CurrentStart not stated–present
Last confirmed April 20, 2026
Company network
Leadership on record at Larimar Therapeutics, Inc.
- Carole Ben-Maimon CEO, Board Member
- Carole S. Ben-Maimon CEO, Board Member
- Joseph Truitt Chairman, Board Member
- Michael Celano CFO
- John B. Harlow, Jr. COO
- Frank E. Thomas Board Member
- Jeffrey W. Sherman, MD, FACP Board Member
- Jonathan Leff Board Member
- Thomas E. Hamilton Board Member
- Thomas Edward Hamilton Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Larimar Therapeutics, Inc. (LRMR) | Ph.D., MBA, FAAPS Chief Development Officer | $466,003 | $1,293,329 |
| 2024 | Larimar Therapeutics, Inc. (LRMR) | Ph.D., MBA, FAAPS Chief Development Officer | $440,583 | $1,165,126 |
| 2023 | Larimar Therapeutics, Inc. (LRMR) | Ph.D., MBA, FAAPS Chief Development Officer | $383,144 | $1,381,721 |
| 2022 | Larimar Therapeutics, Inc. (LRMR) | Ph.D., MBA, FAAPS Chief Development Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.